This website uses cookies Read More Ok

Leader in Integrated ICT Hardware & Systems

QuasaR™ Medical Device Uses ESA’s Galileo Satellite to Help Pinpoint Patients on Earth

Posted on: 17 Jul 2020

QuasaR™ Medical Device Uses ESA’s Galileo Satellite to Help Pinpoint Patients on Earth

Think Biosolution is expanding the capabilities of their QuasaR™ remote monitoring device for telehealth to include critical positioning data with help from Galileo, Europe’s global navigation satellite system (GNSS). 

Remote patient monitoring uses at-home point of care devices to remotely measure physical parameters that clinicians can review. This care model is increasingly popular, moving away from clinical settings to home-based care to increase efficiency, reduce cost and avoid clinical infection, a critical factor during COVID. However, point of care devices can typically only measure biometric information and lack locational information about the patient.

Photo: ESA

The QuasaR™ device, which integrates an optical biometric sensor, temperature sensor, motion sensor, GPS, Bluetooth, and haptic feedback system, will now include GNSS capability for increased reliability and accuracy down to one metre.

Dr. Shourjya Sanyal, CEO of Think Biosolution Limited, explained

“Our remote patient monitoring platforms built on our QuasaR™ device is the only solution in the world that specifically addresses this problem of location information by using built-in GNSS technology.”

GNSS enabled devices deliver increased receiver accuracy and reliability over GPS alone, down to an accuracy of one meter.

For geriatric patients or those living with chronic conditions, the QuasaR™ device can use Galileo-based GNSS to locate them in emergencies like falls or cardiac arrest. In healthy adults, the QuasaR™ device uses Galileo based GNSS to calculate the wearer’s exercise speed, running distance, and the number of calories burnt.

Tyndall National Institute leads the European Space Agency Business Incubation Centre (ESA BIC) consortium for Ireland, through which Think Biosolution gained commercial access to Galileo. The consortium includes Athlone Institute of Technology, Maynooth University, and MaREI (Centre for Marine and Renewable Energy), and is funded jointly by ESA and Enterprise Ireland.

“The advantage to our company has not just been technological,” said Sanyal, commenting on the value ESA BIC has brought to the startup. "Our partnership with ESA BIC has helped validate our company in front of both potential clients and investors.”

About Think Biosolution

Think Biosolution is an original design manufacturer (ODM) and technology provider, building customised Remote Patient Monitoring (RPM) platforms for telehealth enterprises and provider organizations. The company designs and builds wearable medical devices using QuasaR™ sensor technology for telehealth brands in the EU and USA.

About Tyndall National Institute

Tyndall is a leading European research centre in integrated ICT (Information and Communications Technology) materials, devices and systems. It is one of Ireland’s six National Labs, specialising in both electronics and photonics. Tyndall works with industry and academia to transform research into products in its core market areas of electronics, communications, energy, health, agri-tech & the environment. With a network of over 200 industry partners and customers worldwide, they are focused on delivering human and economic impact from excellence in research. A research flagship of University College Cork, Tyndall is home to a research community of 600 people of 52 nationalities.

CONTACT DETAILS

For more information, please contact:

Ursula Morrish

Marketing and Communications Manager

Tyndall National Institute

+353 (0) 852372189

ursula.morrish@tyndall.ie